Navigation Links
FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing
Date:1/25/2012

eratosis on the face and scalp saw 75 percent or greater reduction of existing AKs (versus 7-8 percent with placebo), while 44-55 percent of patients with AKs on the trunk and extremities experienced 75 percent or more reduction (versus 7 percent reduction for placebo). Patients treated with Picato® gel saw 37-47 percent complete clearance of lesions on the face and scalp, and 28-42 percent on the trunk and extremities, versus up to 5 percent complete clearance with placebo in all studies. Local skin responses (LSRs) on the face and scalp were observed to peak around day 4 and resolve by day 15 in the majority of patients. LSRs on the trunk and extremities peaked around day 8 and markedly improved by day 29.

The most common adverse events were LSRs and included erythema, flaking/scaling, crusting and swelling. Other AEs occurring in ≥ 2 percent of subjects treated with Picato® gel include pain, pruritus and infection at the application site, as well as periorbital edema and headache.

IMPORTANT SAFETY INFORMATION
For topical use only; not for oral, ophthalmic, or intravaginal use. Eye disorders, including severe eye pain, eyelid edema, eyelid ptosis, periorbital edema can occur after exposure. Patients should wash hands well after applying Picato® gel, and avoid transfer of the drug to the periocular area during and after application. Severe skin reactions in the treated area, including erythema, crusting, swelling, vesiculation/pustulation, and erosion/ulceration, can occur after application. Administration of Picato® gel is not recommended until the skin is healed from any previous drug or surgical treatment. The most common adverse reactions observed in clinical trials (greater than or equal to 2%) are local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis and headache. There are no adequate an
'/>"/>

SOURCE LEO Pharma Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... PAUL, Minn. , Aug. 1, 2014 /PRNewswire/ ... global medical technologies company, announced today that it ... privately held manufacturer of cardiorespiratory diagnostic products based ... MediSoft has served the European cardiorespiratory diagnostics ... generated 2013 revenues of approximately €4.7 million ($6.3 ...
(Date:8/1/2014)... LAWRENCE, Mass. , Aug. 1, 2014  NxStage Medical, ... innovative dialysis products, today announced that Jeffrey H. Burbank ... Financial Officer, will present at the 34 th Annual ... Boston, MA , on Wednesday, August 13 ... event will be made available at http://ir.nxstage.com/ .  ...
(Date:8/1/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... study evaluating ISIS-SMN Rx in infants with spinal ... infant mortality. Isis plans to dose the first infant ... which time Isis will earn an $18 million milestone ... 3 study, ENDEAR, is the first of several planned ...
Breaking Medicine Technology:MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 3MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 4NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5
... MYL ) today commented on its response ... Mylan CEO Heather Bresch said, "We recognize the ... of patients with cancer, particularly the pediatric population, and ... to this important product. While Mylan has not had ...
... IRVINE, Calif., Feb. 14, 2012 Masimo (NASDAQ: ... its mission to "Improve Patient Outcomes and Reduce the Cost ... Applications®," and its confidence that continuous noninvasive hemoglobin monitoring (SpHb®) ... hospital-wide risk-share program for B lood T ransfusion ...
Cached Medicine Technology:Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 2Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 3Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 4Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 5Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 6Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 7
(Date:8/1/2014)... St. Christopher's Hospital for Children announced that ... Innovations with Ed Begley Jr, airing later this year ... , St. Christopher's Hospital for Children offers a wide ... through 21 years of age. With over 220 pediatric ... including autism and childhood obesity. , “St. Christopher’s ...
(Date:8/1/2014)... A new study published in ... contribute to the development of colorectal cancer in patients ... study was authored by Alberto Martin of the University ... intestinal cells to multiply and create tumors in mice ... , “What’s interesting about this study,” said Shahab Mehdizadeh, ...
(Date:8/1/2014)... For many people, forgetfulness becomes more common ... the normal range, slips that seem new or unusual ... merits a closer look, not a panic attack, explains ... Men's Health Watch . , "We don't want ... keys are they are on the path to Alzheimer's ...
(Date:8/1/2014)... 2014 This week marks a significant ... 500th week of paying commissions to its independent distributor ... in January 2005 total $1,405,954,677.06. , MonaVie distributors can ... company pays commissions in 18 different currencies, including: AUD, ... NZD, PLN, USD, SGD, KRW, TWD, THB and GBP. ...
(Date:8/1/2014)... OK (PRWEB) August 01, 2014 Narconon ... from the program at the drug rehab center located ... the year 2001, Narconon Arrowhead is the flagship drug ... from across the United States for services there. Now, ... center has recent outcome studies as well as client ...
Breaking Medicine News(10 mins):Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 2Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 3Health News:Carbs May Contribute to Colon Cancer 2Health News:Worried About Changes in Your Memory? It's Worth A Closer Look, From the August 2014 Harvard Men's Health Watch 2Health News:MonaVie Records 500th Commission Week, Having Paid Out More Than $1.4B in Distributor Commissions 2Health News:Narconon Arrowhead Celebrates 4,300th Graduate from Program 2Health News:Narconon Arrowhead Celebrates 4,300th Graduate from Program 3
... scientists at SUNY Downstate Medical Center in Brooklyn and ... patent for their virtual telemicroscope. This patented software permits ... patients living in remote locations around the world. ... pathology at SUNY Downstate, and Jiang Gu, MD, PhD, ...
... on investigations, -- Three-fifths want high school ... stats and awards from guilty pro,athletes, FAIRFIELD, ... Baseball season-opener approaches, a new national poll,indicates that ... use among,professional athletes., On average, Americans polled ...
... DIEGO, March 27 Gen-Probe Incorporated,(Nasdaq: GPRO ) ... Leerink,Swann "Bugs and Drugs: The Future of Molecular Diagnostics ... approximately 1:20 p.m. Eastern,Time. The presentation is scheduled to ... on the investor information section of Gen-Probe,s website,at ...
... physical disability does, study shows , , THURSDAY, March 27 (HealthDay ... almost as often as physical disability does, Australian researchers report. ... 55, who had paying jobs before a stroke found that ... about the same ratio as in a recent U.S. study, ...
... 27 The Anthem Blue Cross and Blue Shield,Foundation announced ... San Luis,Valley Chapter of the American Red Cross to assist ... bottles, formula and water,and to aid volunteers who are distributing ... been affected by the recent Salmonella water,contamination., "One of ...
... dairy cow is back at her Kansas farm ... surgery performed at Kansas State University,s,Veterinary Medical Teaching ... the veterinary students assigned to,her case, sustained a ... in her right knee ruptured. Dr. David Anderson, ...
Cached Medicine News:Health News:SUNY researcher issued patent for virtual telemicroscope 2Health News:Americans Guess One-Third of Professional Athletes on Performance Enhancing Drugs 2Health News:Americans Guess One-Third of Professional Athletes on Performance Enhancing Drugs 3Health News:Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference 2Health News:Depression After Stroke Can Be Debilitating 2Health News:Anthem Blue Cross and Blue Shield Foundation Donates $7,500 to San Luis Valley American Red Cross to Assist Residents Affected by Water Contamination Crisis 2Health News:'Wildcat Power Cord' Repairs Cruciate Ligament in Dairy Cow's Knee 2Health News:'Wildcat Power Cord' Repairs Cruciate Ligament in Dairy Cow's Knee 3
... industry:, ,AirSeps AirLife On-board Oxygen Concentrators ... their supplemental oxygen passengers and are still ... With the US governments FAA/STC approval for ... Boeing commercial aircraft, AirSep set the standard ...
... Specifications, including colors, subject to change. , ... kg), FreeStyle by AirSep is the only ... patients who know no boundaries. Bold and ... the heart of what it means to ...
... Portable Oxygen Concentrator is the most compact, ... 10 lbs (4.5 kg), this unit was ... highly active oxygen patient., ,Operating as ... technologies of both an oxygen concentrator and ...
... Has improved the quality of life for ... providers a quality product designed with state-of-the-art ... less than 50 pounds can operate through ... of coverage warranties. The M600/605 series with ...
Medicine Products: